戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1964809作成日:2026年10月25日

4-Methylmorpholine → N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide

https://huagongshe.com/reaction/1964809

反応式

関与物質

役割名称HCID仕込み量
反応物4-MethylmorpholineHCID 7972—
反応物Isobutyl chloroformateHCID 62365—
反応物(S)-1-Phenyl-3-propanolamineHCID 2734520—
反応物3-(Biphenyl-4-ylsulfonyl)-1,3-thiazolidine-2-carboxylic acidHCID 57423221—
溶媒TetrahydrofuranHCID 8028—
生成物N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamideHCID 68623385—

反応条件

温度-25 °C

反応手順

N-methyl morpholine (NMM) (3.24 g, 2.5 eq, 32.15 mmol) was added to a solution of a compound of general formula (VIII) (Intermediate 8, 4.50 g, 1 eq, 12.86 mmol), e.g., 3-([1,1′-biphenyl]-4-ylsulfonyl)-1,3-thiazolidine-2-carboxylic acid, in dry THF (100 ml) and the reaction mixture was cooled down to −25° C. To the reaction mixture was then added drop wise, over a period of 5 minutes, isobutyl chloroformate (1.84 g, 1.05 eq, 13.50 mmol) in solution in dry THF (20 ml). The resulting mixture was stirred at −25° C. for 30 minutes, after which time an amine of general formula (IV) or (IV*) (commercial or Intermediate 2, 2.14 g, 1.1 eq, 14.15 mmol), e.g., (3S)-3-amino-3-phenyl-1-propanol, was added in dry THF (20 ml) over a period of 5 minutes. The mixture was allowed to gradually warm to room temperature and stirred overnight at room temperature. The solvent was removed and the residue re-dissolved in ethyl acetate (200 ml). The organic layer was washed subsequently with a saturated solution of ammonium chloride (100 ml), saturated bicarbonate (100 ml) and brine (100 ml). The combined organic phases were dried with magnesium sulfate and concentrated in vacuo, yielding the crude product of general formula ([), e.g., 3-(1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide, as a white solid (6.21 g, 96%). Silica gel chromatography, eluting in isocratic conditions (50% ethyl acetate in hexanes), which gave the separation of the desired two pure diastereoisomers of general formula (I), e.g., (2S)-3-([1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide (more polar compound, 3.1 g), and (2R)-3-([1,1′-biphenyl]-4-ylsulfonyl)-N-[(1S)-3-hydroxy-1-phenylpropyl]-1,3-thiazolidine-2-carboxamide (less polar compound, 3.0 g).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08415480B2
出典データセットuspto-grants-2013_04
ORD IDord-0317478c76a2481cad0c1896af3637c6
出典メモuspto-grants-2013_04